Meyka Pro banner
Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH) Stock Overview

Explore Lantheus Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LNTHNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$107.95
$3.55(3.40%)
U.S. Market opens in 17h 22m

Lantheus Holdings, Inc. (LNTH)

Meyka AI Score

Z

Key Financials

Market Cap7B
P/E Ratio25.23
EPS (TTM)$5.97
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$82.70
3 Months$75.15
1 Year Target$79.46

LNTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lantheus Holdings, Inc. (LNTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $79.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.23 and a market capitalization of 7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.96%
5-Day Change
2.64%
1-Month Change
-1.69%
3-Month Change
24.33%
6-Month Change
58.47%
Year-to-Date (YTD) Change
56.87%
1-Year Change
45.89%
3-Year Change
22.92%
5-Year Change
300.61%
All-Time (Max) Change
1442.10%

Contact Information

978 671 8001
201 Burlington Road, Bedford, MA, 01862

Company Facts

11,930 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions